Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 11;25(8):4232.
doi: 10.3390/ijms25084232.

Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside-Part 1

Giuseppina Gallucci  1 , Fabio Maria Turazza  2 , Alessandro Inno  3 , Maria Laura Canale  4 , Nicola Silvestris  5 , Roberto Farì  6 , Alessandro Navazio  7 , Carmine Pinto  8 , Luigi Tarantini  7
Affiliations
Review

Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside-Part 1

Giuseppina Gallucci et al. Int J Mol Sci. .

Abstract

Atherosclerosis, a complex metabolic-immune disease characterized by chronic inflammation driven by the buildup of lipid-rich plaques within arterial walls, has emerged as a pivotal factor in the intricate interplay between cancer and cardiovascular disease. This bidirectional relationship, marked by shared risk factors and pathophysiological mechanisms, underscores the need for a comprehensive understanding of how these two formidable health challenges intersect and influence each other. Cancer and its treatments can contribute to the progression of atherosclerosis, while atherosclerosis, with its inflammatory microenvironment, can exert profound effects on cancer development and outcomes. Both cancer and cardiovascular disease involve intricate interactions between general and personal exposomes. In this review, we aim to summarize the state of the art of translational data and try to show how oncologic studies on cardiotoxicity can broaden our knowledge of crucial pathways in cardiovascular biology and exert a positive impact on precision cardiology and cardio-oncology.

Keywords: atherosclerosis; cancer; cardiovascular disease (CVD); endothelium; exposome; immune system; inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Central illustration of atherosclerosis and cancer: shared risk factors, shared pathways, cancer therapy-induced vasculotoxicity; the characters of the atherosclerotic play: the protective characters, the damaging characters, and the damage amplifiers.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization. WHO Department of Data and Analytics . WHO Methods and Data Sources for Global Burden of Disease Estimates, 2000–2019. World Health Organization; Geneva, Switzerland: 2020.
    1. Global Cardiovascular Risk Consortium. Magnussen C., Ojeda F.M., Leong D.P., Alegre-Diaz J., Amouyel P., Aviles-Santa L., De Bacquer D., Ballantyne C.M., Bernabé-Ortiz A., et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N. Engl. J. Med. 2023;389:1273–1285. doi: 10.1056/NEJMoa2206916. - DOI - PMC - PubMed
    1. Townsend N., Kazakiewicz D., Lucy Wright F., Timmis A., Huculeci R., Torbica A., Gale C.P., Achenbach S., Weidinger F., Vardas P. Epidemiology of cardiovascular disease in Europe. Nat. Rev. Cardiol. 2022;19:133–143. doi: 10.1038/s41569-021-00607-3. - DOI - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. GBD 2019 Cancer Risk Factors Collaborators The global burden of cancer attributable to risk factors, 2010–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400:563–591. doi: 10.1016/S0140-6736(22)01438-6. - DOI - PMC - PubMed